Jens Kort

2.9k total citations
61 papers, 1.4k citations indexed

About

Jens Kort is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Jens Kort has authored 61 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hepatology, 24 papers in Infectious Diseases and 21 papers in Epidemiology. Recurrent topics in Jens Kort's work include Hepatitis C virus research (40 papers), HIV/AIDS drug development and treatment (22 papers) and Liver Disease Diagnosis and Treatment (11 papers). Jens Kort is often cited by papers focused on Hepatitis C virus research (40 papers), HIV/AIDS drug development and treatment (22 papers) and Liver Disease Diagnosis and Treatment (11 papers). Jens Kort collaborates with scholars based in United States, Germany and United Kingdom. Jens Kort's co-authors include Federico Mensa, Franco Felizarta, Thomas G. Forsthuber, Armen Asatryan, Chih‐Wei Lin, Teresa I. Ng, Fred Poordad, Preethi Krishnan, Tarek Hassanein and Gebhard Koch and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and Hepatology.

In The Last Decade

Jens Kort

57 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jens Kort United States	17	905	717	407	210	129	61	1.4k
Hui‐May Chu United States	9	739 0.8×	597 0.8×	311 0.8×	25 0.1×	114 0.9×	21	1.0k
Jean‐Maurice Dumont Switzerland	13	481 0.5×	383 0.5×	198 0.5×	125 0.6×	588 4.6×	14	1.1k
Xuemei Yu China	17	347 0.4×	351 0.5×	55 0.1×	69 0.3×	272 2.1×	33	920
Tom Chu United States	14	399 0.4×	583 0.8×	161 0.4×	101 0.5×	157 1.2×	21	872
Xiumei Chi China	18	512 0.6×	504 0.7×	80 0.2×	213 1.0×	175 1.4×	53	917
K Mitamura Japan	14	318 0.4×	263 0.4×	27 0.1×	130 0.6×	259 2.0×	45	909
Nikolai Novikov United States	11	231 0.3×	325 0.5×	282 0.7×	139 0.7×	291 2.3×	19	821
Hong Shang China	17	73 0.1×	201 0.3×	185 0.5×	209 1.0×	273 2.1×	67	841
Christina Gavegnano United States	17	58 0.1×	173 0.2×	472 1.2×	237 1.1×	183 1.4×	32	975
Rakesh Bhat Canada	10	105 0.1×	174 0.2×	42 0.1×	161 0.8×	252 2.0×	27	630

Countries citing papers authored by Jens Kort

Since Specialization

Citations

This map shows the geographic impact of Jens Kort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Kort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Kort more than expected).

Fields of papers citing papers by Jens Kort

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Kort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Kort. The network helps show where Jens Kort may publish in the future.

Co-authorship network of co-authors of Jens Kort

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Kort. A scholar is included among the top collaborators of Jens Kort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Kort. Jens Kort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Othman, Mohamed O., Christopher E. Forsmark, Dhiraj Yadav, et al.. (2024). Development of clinical screening tool for exocrine pancreatic insufficiency in patients with definite chronic pancreatitis. Pancreatology. 24(4). 545–552. 1 indexed citations

Sise, Meghan E., Min Xu, David S. Goldberg, et al.. (2023). Early initiation of glecaprevir/pibrentasvir after transplantation of HCV‐viremic kidneys into HCV‐negative recipients is associated with normalization in the altered inflammatory milieu. Clinical Transplantation. 37(4). e14926–e14926.

Wang, Gary P., Gretja Schnell, Jens Kort, et al.. (2021). Linkage of resistance-associated substitutions in GT1 sofosbuvir + NS5A inhibitor failures treated with glecaprevir/pibrentasvir. Journal of Hepatology. 75(4). 820–828. 1 indexed citations

Flamm, Steven L., Jens Kort, Steven E. Marx, et al.. (2020). Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve, Compensated Cirrhotic Patients with Chronic Hepatitis C Infection. Advances in Therapy. 37(5). 2267–2274. 14 indexed citations

Lok, Anna S., Mark Sulkowski, Jens Kort, et al.. (2019). Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy. Gastroenterology. 157(6). 1506–1517.e1. 34 indexed citations

Kosloski, Matthew P., Daniel A.J. Bow, Ryota Kikuchi, et al.. (2019). Translation of In Vitro Transport Inhibition Studies to Clinical Drug-Drug Interactions for Glecaprevir and Pibrentasvir. Journal of Pharmacology and Experimental Therapeutics. 370(2). 278–287. 16 indexed citations

Poordad, Fred, Stanislas Pol, Armen Asatryan, et al.. (2017). Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct‐acting antiviral treatment failure. Hepatology. 67(4). 1253–1260. 105 indexed citations

Forns, Xavier, Samuel S. Lee, Joaquin Valdes, et al.. (2017). Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial. The Lancet Infectious Diseases. 17(10). 1062–1068. 234 indexed citations

Gane, Edward, Fred Poordad, Stanley Wang, et al.. (2016). High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis. Gastroenterology. 151(4). 651–659.e1. 72 indexed citations

10.

Kosloski, Matthew P., et al.. (2016). ABT-493 and ABT-530 Combination Demonstrated Minimal Potential for CYP-Mediated Drug-Drug Interactions. Journal of Hepatology. 64(2). S405–S405. 5 indexed citations

11.

Dieterich, Douglas T., Mark Nelson, Vincent Soriano, et al.. (2015). Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV. AIDS. 29(5). 571–581. 10 indexed citations

12.

Escalante, Patricio, Rizwana Khan, San San Aye, et al.. (2014). Diagnosis of Latent Tuberculosis Infection with T-SPOT®.TB in a Predominantly Immigrant Population with Rheumatologic Disorders. Lung. 193(1). 3–11. 6 indexed citations

13.

Sabo, John P., Jens Kort, Manuel Haschke, et al.. (2014). Clinical Assessment of Potential Drug Interactions of Faldaprevir, a Hepatitis C Virus Protease Inhibitor, With Darunavir/Ritonavir, Efavirenz, and Tenofovir. Clinical Infectious Diseases. 59(10). 1420–1428. 5 indexed citations

14.

Denkinger, Claudia M., Michael Denkinger, Jens Kort, Christine N. Metz, & Thomas G. Forsthuber. (2003). In Vivo Blockade of Macrophage Migration Inhibitory Factor Ameliorates Acute Experimental Autoimmune Encephalomyelitis by Impairing the Homing of Encephalitogenic T Cells to the Central Nervous System. The Journal of Immunology. 170(3). 1274–1282. 94 indexed citations

15.

Forsthuber, Thomas G., Carey L. Shive, Wolfgang Wienhold, et al.. (2001). T Cell Epitopes of Human Myelin Oligodendrocyte Glycoprotein Identified in HLA-DR4 (DRB1*0401) Transgenic Mice Are Encephalitogenic and Are Presented by Human B Cells. The Journal of Immunology. 167(12). 7119–7125. 71 indexed citations

16.

Leahy, Kevin, et al.. (1999). adapt78, a Stress-Inducible mRNA, Is Related to the Glucose-Regulated Protein Family of Genes. Archives of Biochemistry and Biophysics. 368(1). 67–74. 35 indexed citations

17.

Kort, Jens. (1998). Impairment of Excitatory Amino Acid Transport in Astroglial Cells Infected with the Human Immunodeficiency Virus Type 1. AIDS Research and Human Retroviruses. 14(15). 1329–1339. 39 indexed citations

18.

Kort, Jens & Tuula O. Jalonen. (1998). The nef protein of the human immunodeficiency virus type 1 (HIV-1) inhibits a large-conductance potassium channel in human glial cells. Neuroscience Letters. 251(1). 1–4. 19 indexed citations

19.

Kort, Jens & Gebhard Koch. (1990). The Na⁺,K⁺,2Cl⁻‐cotransport system in HeLa cells: Aspects of its physiological regulation. Journal of Cellular Physiology. 145(2). 253–261. 14 indexed citations

20.

Kort, Jens & Gebhard Koch. (1989). The Na⁺, K⁺, 2Cl⁻‐cotransport system in HeLa cells and HeLa cell mutants exhibiting an altered efflux pathway. Journal of Cellular Physiology. 141(1). 181–190. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact